Gluten Immunogenic Peptides (GIP) Point-of-Care Urine Test in Coeliac Disease Follow-up before and during the COVID-19 Lockdown in Italy.

Pierpaolo Cavallo Mario Gagliardi Monica SiniscalchiMonica RuotoloAntonella Santonicola Najla Hajji Fabiana Zingone

Published in: Clinical and experimental gastroenterology (2021)

The GIP test is a tool that can be used as a point of care test to assess adequate compliance with GFD and reassure symptomatic CeD patients from the feeling of anxiety for gluten contamination, especially during the COVID-19 pandemic.

Keyphrases

end stage renal disease
coronavirus disease
ejection fraction
sars cov
chronic kidney disease
newly diagnosed
celiac disease
risk assessment
prognostic factors
depressive symptoms
physical activity
climate change
sleep quality